• 제목/요약/키워드: Cholangitis

검색결과 70건 처리시간 0.018초

랑게르한스세포 조직구증 환아에서 발생한 속발성 경화성 담관염 1례 (A Case of Secondary Sclerosing Cholangitis in Langerhans Cell Histiocytosis)

  • 김자형;최보화;김경모;문형남
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제4권1호
    • /
    • pp.120-124
    • /
    • 2001
  • 저자들은 복부 팽만과 지속적인 황달을 주소로 내원한 랑게르한스세포 조직구증 환아에서 간조직 검사 및 내시경적 역행성 담도조영술로 진단한 속발성 경화성 담관염 1례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

  • PDF

Risk Factors for Post-ERCP Cholangitis in Patients with Pancreatic Cancer from a Single Referral Center in Iran

  • Salehimarzijarani, Babak;Dadvar, Zohreh;Mousavi, Mirhadi;Mirsattari, Dariush;Zali, Mohammad Reza;Alizadeh, Amir Houshang Mohammad
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권4호
    • /
    • pp.1539-1541
    • /
    • 2012
  • Cholangitis is relatively uncommon but associated mortality is high due to the predisposition in people with underlying disease. For this recognition of contributing risk factors is necessary. Therefore, the present descriptive-analytical cross-sectional survey was designed to determine contributing risk factors for post-ERCP cholangitis in patients with pancreatic cancer. From 2005 to 2010, 110 consecutive cases of pancreatic cancer attending to a tertiary referral centre (Taleghani Hospital), Tehran, Iran were recruited. The patients all underwent stenting via endoscopic retrograde cholangiopancreatography (ERCP). On univariate analysis, a metallic stent type (95% confidence interval (CI) 1.025-11.34, P=0.037), having no jaundice (1.44-2.22, P=0.009), having no pain (1.32-1.91, P=0.026), a history of prior ERCP (1.16-10.37, P=0.020), and having a proximal biliary stone (1.002-5.93, P=0.046) were related to cholangitis. However on multivariate analysis, none of these factors were found to be contributing risk factors. Cholangitis is avoidable with adequate biliary drainage. Because success rates are higher and complication rates lower for endoscopists performing large volumes of ERCP, performance of the procedure should be concentrated as much as possible in institutions with endoscopists having adequate experience. Patients with a high risk for complications may be best served by referral to an advanced center.

Analysis of Cholangitis Rates with Extended Perioperative Antibiotics and Adjuvant Corticosteroids in Biliary Atresia

  • Goh, Lynette;Phua, Kong Boo;Low, Yee;Chiang, Li Wei;Yong, Chen;Chiou, Fang Kuan
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제24권4호
    • /
    • pp.366-376
    • /
    • 2021
  • Purpose: There is no consensus regarding adjuvant therapies following Kasai portoenterostomy (KP) for biliary atresia (BA). This study aimed to analyze the effect of extended perioperative intravenous antibiotics (PI-Abx) and adjuvant corticosteroid on cholangitis and jaundice clearance rates in the 3 years post-KP in children with BA. Methods: Data of patients who underwent KP between 1999-2018 at a single center were retrospectively analyzed. Group A (1999-2010) received PI-Abx for 5 days, Group B (2010-2012) received PI-Abx for 5 days plus low-dose prednisolone (2 mg/kg), and Group C (2012-2017) received PI-Abx for 14 days plus high-dose prednisolone (5 mg/kg). Results: Fifty-four patients were included with groups A, B, and C comprising 25, 9, and 20 patients, respectively. The number of episodes of cholangitis was 1.0, 1.6, and 1.3 per patient (p=NS) within the first year and 1.8, 2.3, and 1.7 (p=NS) over 3 years in Groups A, B, and C, respectively. The jaundice clearance rate at 6 months was 52%, 78%, and 50% (p=NS), and the 3-year native liver survival (NLS) rate was 76%, 100%, and 80% (p=NS) in Groups A, B, and C, respectively. A near-significant association was observed between the incidence of cholangitis within the first year and decompensated liver cirrhosis/death at 3 years post KP (p=0.09). Persistence of jaundice at 6 months was significantly associated with decompensated cirrhosis/death at 3 years (p<0.001). Conclusion: The extended duration of PI-Abx and adjuvant corticosteroids was not associated with improved rates of cholangitis, jaundice clearance, or NLS in patients with BA.

Caroli's Disease로 인한 담관염 환자 치험 1례 (Treated One Case of Cholangitis Due to Caroli's Disease)

  • 문미현;이성균;정현애;이정섭;임은경;이윤재;문구;신선호;김동웅;조영기
    • 대한한방내과학회지
    • /
    • 제26권4호
    • /
    • pp.912-917
    • /
    • 2005
  • Caroli's disease is a non-obstructive dilatation of the intrahepatic bile ducts. It is a rare congenital disorder that classically causes saccular ductal dilatation, which usually it segmental dilatation. Caroli's disease is associated with recurrent bacterial cholangitis and stone formation. A 57 years-old female inpatient suffering from cholangitis due to Caroli's disease was admitted at Wonkwang University Jeonju Oriental Medicine Hospital. The patient was treated with herbal medicine such as Yongdamsagan-tang and acupuncture. As result, there was improvement of symptoms. The process and content of treatment and the patient's recovery over general symptoms is described.

  • PDF

자가면역간염과 원발성 경화담관염을 가진 중복증후군 소아 환자에서 발생한 형질세포성 골수염 1예 (A Case of Chronic Lymphoplasmacellular Osteomyelitis with Autoimmune Hepatitis/Primary Sclerosing Cholangitis Overlap Syndrome in a Child)

  • 이지혁;이현영;김진규;이지현;최연호
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제10권1호
    • /
    • pp.91-97
    • /
    • 2007
  • 저자들은 4세에 진단된 자가면역간염과 궤양성 대장염 그리고 6세에 진단된 원발성 경화담관염을 가진 중 복증후군 환아에서 9세에 만성 림프형질세포성 골수염이 발병한 뒤 면역억제 치료에 잘 반응하지 않는 증례를 경험하였기에 보고하는 바이다.

  • PDF

재발성화농성담관염에 대한 치험 1례 (A case of recurrent pyogenic cholangitis with herbal medicine)

  • 김성환;홍상훈
    • 대한한방내과학회지
    • /
    • 제22권4호
    • /
    • pp.761-764
    • /
    • 2001
  • Recurrent Pyogenic Cholangitis(RPC) is a distinct clinical entity characterized by recurrent attacks of fever, chills, abdominal pain, and jaundice caused by bacterial infection. In 27, July, 2000, We treated a 40-year-old male patient, complained of these symptoms : severe abdominal pain, fatigue, indigestion, interval chilling. We diagnosed as stagnation of the liver-qi and Qi(肝鬱氣滯), gave herbal medicine composited with Herba Lysimachiae(金錢草), Spora Lygodii(海金沙), Herba Artemisiae Scopariae(茵蔯).etc. After treatment, main symptoms were disappeared and stone of common bile duct was removed. As a consequence, herbal medicine treatment was not toxic to liver function and good effect on RPC induced symptoms.

  • PDF

카사이 수술 후 발생한 간내 담관 낭종 (The Development of a Intrahepatic Biliary Cyst after Kasai Operation for Biliary Atresia)

  • 박우현;최순옥
    • Advances in pediatric surgery
    • /
    • 제5권2호
    • /
    • pp.126-129
    • /
    • 1999
  • A 6 and a half year-old girl developed recurrent cholangitis following hepatic portoenterostomy for biliary atresia. Computed tomogram showed an ovoid cyst ($4.5{\times}4.0$ cm in size) in the left hepatic lobe and another tubular dilatation ($2.0{\times}0.8$ cm in size) in the right hepatic lobe. Percutaneous transhepatic cholangiodrainage(PTCD) and cystogram showed an ovoid cyst in the left hepatic lobe (Tsuchida type A), measuring $6.6{\times}5.0$ cm in size. Following drainage and administration of parenteral antibiotics she became afebrile and anicteric. However she continued to drain 45-150 cc of bile per day via the tube over the next 2 weeks. The patient successfully underwent intrahepatic cystojejunostomy with intraoperative ultrasonographic guidance. This case illustrates relapsing cholangitis caused by Tsuchida type A intrahepatic cyst, successfully managed with PTCD followed by an internal drainage procedure.

  • PDF

Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative Colitis

  • Buness, Cynthia;Lindor, Keith D.;Miloh, Tamir
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제19권3호
    • /
    • pp.210-213
    • /
    • 2016
  • Primary sclerosing cholangitis (PSC), a rare progressive liver disease characterized by cholestasis and bile duct fibrosis, has no accepted, effective therapy known to delay or arrest its progression. We report a 15 year old female patient diagnosed with PSC and moderate chronic active ulcerative colitis (UC) who achieved normalization of her liver enzymes and bile ducts, and resolution of her UC symptoms with colonic mucosal healing, after treatment with a single drug therapy of the antibiotic oral vancomycin. We postulate that the oral vancomycin may be acting both as an antibiotic by altering the intestinal microbiome and as an immunomodulator. Oral vancomycin may be a promising treatment for PSC that needs to be further studied in randomized trials.

카사이 수술 후 장기생존환자의 간 자기공명영상 소견 (MRI Findings of Long-term Survivals after Kasai Portoenterostomy)

  • 정지광;정은영;박우현;최순옥
    • Advances in pediatric surgery
    • /
    • 제18권1호
    • /
    • pp.12-17
    • /
    • 2012
  • The purpose of this study is to analyse clinical impact of specific MRI findings in liver in patients of long-term survivors after Kasai portoenterostomy (KPE). Twenty-eight patients who were underwent KPE were followed up more than 5 years. Macro-regenerative nodule (MRN) and beaded-duct dilatation (BDD) were considered as important findings in liver MRI. The association between these findings in MRI and clinical indicator, serum bilirubin level and history of cholangitis were evaluated. Sixteen patients (57.1%) were shown MRN in liver MRI. Therewere 14 patients(50%) whose MRI showed BDD. Serum total and direct bilirubin were 3.6 mg/dL and 1.8 mg/dL respectively in positive MRN group whereas 1.4 mg/dL and 0.7 mg/dL in negative MRN group (p = 0.427). Serum total and direct bilirubin level were 4.2 mg/dL and 2.1 mg/dL in patients with BDD negative group compare to 1.1 mg/dL and 0.5 mg/dL in BDD positive group (p = 0.281). The odds ratio to have cholangitis in the patient with MRN was 2.3 and 0.53 in patient with BDD in their MRI findings. MRN in liver MRI may suggest high bilirubin level and more chance to have cholangitis, but the findings of BDD may related to low bilirubin level and less change to have cholangitis.

  • PDF